JP2010511389A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2010511389A5 JP2010511389A5 JP2009539524A JP2009539524A JP2010511389A5 JP 2010511389 A5 JP2010511389 A5 JP 2010511389A5 JP 2009539524 A JP2009539524 A JP 2009539524A JP 2009539524 A JP2009539524 A JP 2009539524A JP 2010511389 A5 JP2010511389 A5 JP 2010511389A5
- Authority
- JP
- Japan
- Prior art keywords
- circulating
- fibrosis
- subject
- disease
- fibrotic
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US87201906P | 2006-11-30 | 2006-11-30 | |
| US60/872,019 | 2006-11-30 | ||
| PCT/US2007/086167 WO2008067559A2 (en) | 2006-11-30 | 2007-11-30 | Methods for treating and diagnosing fibrotic and fibroproliferative diseases |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2010511389A JP2010511389A (ja) | 2010-04-15 |
| JP2010511389A5 true JP2010511389A5 (https=) | 2011-01-20 |
| JP5296701B2 JP5296701B2 (ja) | 2013-09-25 |
Family
ID=39468768
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2009539524A Expired - Fee Related JP5296701B2 (ja) | 2006-11-30 | 2007-11-30 | 線維性疾患および線維増殖性疾患を処置および診断するための方法 |
Country Status (5)
| Country | Link |
|---|---|
| US (2) | US8114608B2 (https=) |
| EP (1) | EP2100140B1 (https=) |
| JP (1) | JP5296701B2 (https=) |
| AU (1) | AU2007325029B2 (https=) |
| WO (1) | WO2008067559A2 (https=) |
Families Citing this family (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| KR101466931B1 (ko) | 2006-07-18 | 2014-12-02 | 녹손 파르마 아게 | Sdf-1 결합형 b형 핵산분자 |
| US8772257B2 (en) * | 2007-08-06 | 2014-07-08 | Noxxon Pharma Ag | SDF-1 binding nucleic acids and the use thereof |
| JP2012506558A (ja) * | 2008-10-22 | 2012-03-15 | アローキュア インコーポレイテッド | 腎損傷および他の主要な器官を処置するための、診断用および間葉系幹細胞（多能性間質細胞）特異的な治療用のバイオマーカーとしてのｓｄｆ−１（ｃｘｃｌ１２）を使用する方法 |
| JP2012127879A (ja) * | 2010-12-16 | 2012-07-05 | Kanazawa Univ | 腎症の進行度の判定方法並びに線維化抑制剤。 |
| CN103376228B (zh) * | 2012-04-27 | 2016-02-17 | 中国人民解放军军事医学科学院放射与辐射医学研究所 | 一种检测或辅助检测放射性肺纤维化的试剂盒 |
| WO2014139884A2 (en) * | 2013-03-14 | 2014-09-18 | Galapagos Nv | Molecular targets and compounds, and methods to identify the same, useful in the treatment of fibrosis |
| JP6601707B2 (ja) * | 2015-02-15 | 2019-11-06 | 国立大学法人金沢大学 | 線維化判定方法 |
| JP7126668B2 (ja) * | 2017-08-09 | 2022-08-29 | 国立大学法人金沢大学 | 膠原病判定方法 |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6759036B1 (en) * | 1997-03-28 | 2004-07-06 | The Picower Institute For Medical Research | Fibrocyte-base vaccine formulations |
| US8293479B2 (en) * | 2002-05-02 | 2012-10-23 | Los Angeles Biomedical Research Institute At Harbor Ucla Medical Center | Use of parathyroid hormone-related protein(PTHRP) in the diagnosis and treatment of chronic lung disease and other pathologies |
| PT1596880E (pt) * | 2002-12-23 | 2011-06-06 | Univ Rice William M | Métodos e composições para suprimir a diferenciação de fibrócitos |
-
2007
- 2007-11-30 AU AU2007325029A patent/AU2007325029B2/en not_active Ceased
- 2007-11-30 JP JP2009539524A patent/JP5296701B2/ja not_active Expired - Fee Related
- 2007-11-30 EP EP20070865037 patent/EP2100140B1/en active Active
- 2007-11-30 US US12/516,912 patent/US8114608B2/en not_active Expired - Fee Related
- 2007-11-30 WO PCT/US2007/086167 patent/WO2008067559A2/en not_active Ceased
-
2011
- 2011-12-15 US US13/327,025 patent/US8216796B2/en active Active
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2010511389A5 (https=) | ||
| JP2021523103A (ja) | Ｉｌ−３３を含有するマトリックス結合型小胞（ｍｂｖｓ）およびそれらの使用 | |
| JP2022113802A (ja) | 心不全の治療方法 | |
| He et al. | Ultrastructure of mitochondria and the endoplasmic reticulum in renal tubules of Dahl salt-sensitive rats | |
| Kazantsev et al. | Hybrid revascularization of the heart and brain: which carotid endarterectomy is preferable? | |
| CN120898134A (zh) | Mpo抑制剂治疗方法 | |
| Zhu et al. | Lund exhaust on hemodynamic parameters and inflammatory mediators in patients undergoing cardiac valve replacement under cardiopulmonary bypass | |
| Figuinha et al. | Heyde's syndrome: case report and literature review | |
| Sun et al. | Contrast-Induced Nephropathy: further investigations about risk factors are required | |
| Lu et al. | Olmesartan medoxomil reverses glomerulosclerosis in renal tissue induced by myocardial infarction without changes in renal function | |
| Tanaka et al. | Aortic valve replacement for aortic regurgitation with rare left ventricular non-compaction | |
| Mahung et al. | 41 Peripheral Mononuclear Cell Expression of IL-10, IL-12, ARG1, & NOS2 Correlates with Outcomes After Burn | |
| Bankir et al. | MO422: Strong Positive Association Between GFR and the Urine-To-Plasma Urea Concentration Ratio in Patients With Sickle Cell Disease. Possible Functional Meaning | |
| Mesani et al. | Biomechanical Characterization and Remodeling of Pulmonary Arteries in Chronic Thromboembolic Pulmonary Hypertension | |
| Tayyareci et al. | Intracoronary Autologous Bone Marrow− Derived Mononuclear Cell Transplantation Improves Coronary Collateral Vessel Formation and Recruitment Capacity in Patients With Ischemic Cardiomyopathy: A Combined Hemodynamic and Scintigraphic Approach | |
| Moore et al. | Circulating Monocytes In Idiopathic Pulmonary Fibrosis (ipf) Patients Express Tlr9 And Cd206 | |
| Hijazi et al. | OP-134: PERIOPERATIVE ADMINISTRATION OF LEVOSIMENDAN TO PATIENTS WITH PREOPERATIVE LEFT VENTRICULAR DYSFUNCTION WHO ARE EXPECTED NOT TO BE WEANED FROM CARDIOPULMONARY BYPASS EASILY | |
| Tserendavaa et al. | TCTAP A-054 The Study Endothelial Nitric Oxide Synthase Enzyme of EPC Colonies in the Coronary Atherosclerosis | |
| Baernthaler et al. | Inhibiting Prostaglandin E2 Degradation Is Protective in a Mouse Model of Pulmonary Fibrosis | |
| Debicka-Dabrowska et al. | [PP. 36.04]: USEFULNESS OF SLOW BREATHING TRAINING IN CHRONIC HEART FAILURE. STUDY DESIGN AND INTERMEDIATE RESULTS | |
| Omoto et al. | Aortic valve replacement in a patient with alpha-thalassemia | |
| Peroš-Golubičić | 15 Scleroderma and Lung | |
| Wein et al. | The cardiomyopathies | |
| Qin et al. | Targeting Ischaemia-reperfusion (IR) Injury in the Intact Heart with Annexin-A1 (ANX-A1) Mimetics | |
| Rebeko et al. | ELECTROPHYSIOLOGY DATA IN HYPERTENSIVE PATIENTS WITH AND WITHOUT HYPERTROPHY: PP. 36.226 |